Last reviewed · How we verify

NCT03771794

Heart Rate Variability Augmentation With RR2 Neuromodulation Device

Status unknown NA Last updated 11 December 2018
What this trial tests

NA trial testing ReguRate neurostimulation in Healthy in 60 participants. Status unknown.

Timeline
15 November 2018
Primary endpoint
15 November 2019
15 December 2019

Quick facts

Lead sponsorHillel Yaffe Medical Center
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposetreatment
Enrollment60
Start date15 November 2018
Primary completion15 November 2019
Estimated completion15 December 2019
Sites2 locations across Israel

Drugs / interventions tested

Conditions studied

Sponsor

Hillel Yaffe Medical Center

Who can join

Adults 25 to 60, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Brief Summary: A randomized double-blinded, sham-controlled, crossover study Condition or Disease: impaired autonomic balance measured by heart rate variability

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

Other Hillel Yaffe Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03771794.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing